Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05579847 · ClinicalTrials.gov registry record
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 20
- Enrollment target
NCT05579847 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT05579847 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.
Interventions
- OTHER mHealth Smart Phone Application
- BEHAVIORAL eHEALS digital literacy test
- BEHAVIORAL Weekly Quiz
- BEHAVIORAL European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
- BEHAVIORAL Patient Post Intervention Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2024-11-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05579847
The ClinicalTrials.gov registry entry for NCT05579847 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which mHealth Smart Phone Application is the first listed.
NCT05579847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05579847 about?
NCT05579847 is a clinical study titled "Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy". The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.
What is the current status of trial NCT05579847?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-10-19. Estimated completion is 2024-11-04.
What interventions are being tested in trial NCT05579847?
The interventions under investigation include: mHealth Smart Phone Application (OTHER), eHEALS digital literacy test (BEHAVIORAL), Weekly Quiz (BEHAVIORAL), European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (BEHAVIORAL), Patient Post Intervention Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05579847?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.